Gainers
Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.
The most overbought stocks in the communication services sector present a potential opportunity to go short on these overvalued companies. Here’s the latest list of major overbought players in this sector.